Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 07/31/06
Due: 07/31/07
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Pharmacology Study of AZD7295 in Healthy Subjects | NCT00906256 | Arrow Therapeutics | user2@example.com | None | 2009-04-30 | 2009-07-31 | 2010-07-31 | - | - | 2025-07-14 |
| Pharmacokinetics of AZD7295 Capsules | NCT01097408 | Arrow Therapeutics | user2@example.com | None | 2010-03-31 | 2010-08-31 | 2011-08-31 | - | - | 2025-07-14 |
| Antiviral Activity of AZD7295 in HCV Carriers | NCT00781976 | Arrow Therapeutics | user2@example.com | None | 2008-11-30 | 2010-03-31 | 2011-03-31 | - | - | 2025-07-14 |
| A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers | NCT00522808 | Arrow Therapeutics | user2@example.com | None | 2007-08-31 | 2008-05-31 | 2009-05-31 | - | - | 2025-07-14 |
| A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT | NCT00232635 | Arrow Therapeutics | user2@example.com | None | 2005-09-30 | 2006-07-31 | 2007-07-31 | - | - | 2025-07-14 |